M. Holtkamp
Impact in
- Hematology top 10%
- Hematopoietic Stem Cell Transplantation
-
- PARP inhibition in cancer therapy
- Cancer Treatment and Pharmacology
Papers in
- Oncology 6
- Cancer Treatment and Pharmacology 2
- PARP inhibition in cancer therapy 2
-
- Central Venous Catheters and Hemodialysis 2
- Co-authors
- Sjoerd Rodenhuis (9 shared papers)Jan H. Schornagel (4 shared papers)Alwin D. R. Huitema (3 shared papers)Jos Beijnen (3 shared papers)I. C. M. Slaper-Cortenbach (4 shared papers)Wim J. Nooijen (2 shared papers)Elsken van der Wall (2 shared papers)Joke W. Baars (4 shared papers)
- Journals
- Annals of Oncology (4 papers)Journal of Clinical Apheresis (1 paper)Journal of Clinical Oncology (1 paper)British Journal of Cancer (1 paper)Therapeutic Drug Monitoring (1 paper)
- Partner nations
- NetherlandsUnited States
In The Last Decade
M. Holtkamp
14 papers receiving 476 citations
Peers
Comparison fields: 5 of 61
- Hematology 95
- Oncology 176
- Cancer Research 68
- Pathology and Forensic Medicine 77
- Genetics 71
Countries citing papers authored by M. Holtkamp
This map shows the geographic impact of M. Holtkamp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Holtkamp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Holtkamp more than expected).
Fields of papers citing papers by M. Holtkamp
This network shows the impact of papers produced by M. Holtkamp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Holtkamp. The network helps show where M. Holtkamp may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Holtkamp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 154 | |
| 2 | 1996 | 82 | |
| 3 | 1994 | 64 | |
| 4 | 2005 | 56 | |
| 5 | 2002 | 54 | |
| 6 | 2003 | 21 | |
| 7 | 1999 | 14 | |
| 8 | 2009 | 12 | |
| 9 | 2013 | 11 | |
| 10 | Mobilisation of blood progenitor cells with ifosfamide and etoposide (VP-16) in combination with recombinant human G-CSF (Filgrastim) in patients with malignant lymphomas or solid tumours. | 1996 | 10 |
| 11 | 1997 | 5 | |
| 12 | 2023 | 4 | |
| 13 | 2025 | 3 | |
| 14 | 2017 | 1 | |
| 15 | 2026 | 0 |
About M. Holtkamp
M. Holtkamp is a scholar working on Oncology, Emergency Medical Services, Hematology, Cancer Research and Pharmacology, having authored 15 papers that have together received 491 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), BRCA gene mutations in cancer (2 papers), Cancer Treatment and Pharmacology (2 papers), PARP inhibition in cancer therapy (2 papers), Central Venous Catheters and Hemodialysis (2 papers), Microfluidic and Bio-sensing Technologies (1 paper) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Hematology (95 citations), Oncology (176 citations), Cancer Research (68 citations), Pathology and Forensic Medicine (77 citations) and Genetics (71 citations). M. Holtkamp has collaborated with scholars based in Netherlands and United States. Frequent co-authors include Sjoerd Rodenhuis, Jan H. Schornagel, Alwin D. R. Huitema, Jos Beijnen, I. C. M. Slaper-Cortenbach, Wim J. Nooijen, Elsken van der Wall, Joke W. Baars, Jolanda G. Schrama and Otilia Dalesio. Their work appears in journals such as Annals of Oncology, Journal of Clinical Apheresis, Journal of Clinical Oncology, British Journal of Cancer and Therapeutic Drug Monitoring.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.